Stock Research: Pro Medicus

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Pro Medicus

ASX:PME AU000000PME8
50
  • Value
    4
  • Growth
    77
  • Safety
    Safety
    11
  • Combined
    18
  • Sentiment
    76
  • 360° View
    360° View
    50
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Pro Medicus Limited is a healthcare informatics company providing medical imaging software and services. It operates in the medical imaging software industry with products like Visage RIS, Visage 7, and Visage Ease. The company serves hospitals, imaging centers, and healthcare groups in Australia, North America, and Europe. In the last fiscal year, the company had a market cap of $22457 million, profits of $111 million, and revenue of $111 million.

more
Index
ASX 100
ASX 200
ASX 300
ASX 50
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
4 5 10 17
Growth
77 99 97 87
Safety
Safety
11 11 83 83
Sentiment
76 81 66 54
360° View
360° View
50 50 78 62
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
42 5 15 13
Opinions Change
67 91 40 50
Pro Holdings
n/a 83 84 42
Market Pulse
68 82 89 90
Sentiment
76 81 66 54
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
4 5 10 17
Growth
77 99 97 87
Safety Safety
11 11 83 83
Combined
18 18 86 86
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
1 1 1 2
Price vs. Earnings (P/E)
3 3 10 14
Price vs. Book (P/B)
1 1 1 3
Dividend Yield
23 48 57 64
Value
4 5 10 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
93 96 81 46
Profit Growth
69 64 60 62
Capital Growth
90 65 89 94
Stock Returns
5 99 87 81
Growth
77 99 97 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
93 91 89 73
Refinancing
13 17 11 11
Liquidity
15 15 91 91
Safety Safety
11 11 83 83

Similar Stocks

Discover high‑ranked alternatives to Pro Medicus and broaden your portfolio horizons.

Ship Healthcare Holdings

TYO:3360
Country: Japan
Industry: Health Care Distributors
Size: Medium
Full Stock Analysis

BML

TYO:4694
Country: Japan
Industry: Health Care Services
Size: Medium
Full Stock Analysis

Kelsian

ASX:KLS
Country: Australia
Industry: Highways & Railtracks
Size: Medium
Full Stock Analysis

Alfresa Holdings

TYO:2784
Country: Japan
Industry: Health Care Distributors
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This is a classic, high-risk growth play: high growth and positive sentiment outweigh low Value Rank (expensive) and risky financing. This is for aggressive growth investors who are comfortable with the high price and risk, believing the growth story justifies the expense.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: